Expression of the immunogenic HuD molecule by SCLC elicits the production of anti-Hu aAb and CD8+ cytotoxic T cells, explaining the parallel clinical course of neurological symptoms and SCLC evolution and demonstrating the direct link between cancer and tissue-specific AID (10). The gene discussed is AICDA; the disease is cancer.